Skip to main content

Table 4 Lipid profile: concentrations and ratios, by MS status and particle size phenotype (N = 185)

From: Observational study of lipid profile and LDL particle size in patients with metabolic syndrome

 

No SM

(N = 72)

SM

(N = 113)

 

Phenotype A

(> 260 Å)

Phenotype B

(≤ 260 Å)

p -value

Phenotype A

(> 260 Å)

Phenotype B

(≤ 260 Å)

p -value

Plasma cholesterol (mg/dL)

188 ± 35.9

245 ± 56

0.103

196.1 ± 83.6

227 ± 48

0.009*

Plasma triglycerides (mg/dL)

101 [70-129.3]

282 [265-298]

0.003*

129 [91-195]

245 [178-296]

> 0.001*

LDL cholesterol (mg/dL)

106.4 ± 31.8

137 ± 54

0.379

112 ± 34

124 ± 32

0.151

HDL cholesterol (mg/dL)

60 [52-69]

52 [47-56]

0.329

53 [41-63]

42 [38-52]

0.072

Apo A-I (mg/dL)

160.6 ± 22.1

168 ± 4.24

0.538

159.37 ± 31.7

158.7 ± 26.5

0.270

Apo A-II (mg/dL)

31 [28-33]

36.5 [35-38]

0.069

32 [27-38]

34 [30-41]

0.934

Apo B (mg/dL)

95.4 ± 23.1

139 ± 24.1

0.025*

105.1 ± 21.4

122.5 ± 31.2

0.014*

Lipoprotein (a) (mg/dL)

18.6 [4.9-43]

1.25 [1.2-1.3]

0.005*

14.3 [4.2-33.7]

19.5 [12.9-47.3]

0.844

Apo B/Apo A-I ratio

0.60 ± 0.16

0.83 ± 0.12

0.050*

0.69 ± 0.19

0.78 ± 0.18

0.023

Plasma cholesterol/HDL-c ratio

3.22 ± 0.84

4.72 ± 0.50

0.016*

3.84 ± 1.18

4.82 ± 1.17

0.001

Plasma triglycerides/HDL-c ratio

1.65 [1.13-2.45]

5.55 [4.73-6.34]

0.003*

2.49 [1.53-3.67]

5.49 [3.99-6.85]

> 0.001*

Log (TG/HDL-c) ratio

0.20 ± 0.24

0.74 ± 0.08

0.003*

0.38 ± 0.29

0.72 ± 0.19

> 0.001*

LDL particle size (Å)

273.6 [271.1-274.7]

255.25 [255-255.5]

0.001*

271.2 [267.7-273.7]

259 [257.6-260]

> 0.001*

  1. Notes: Data are mean ± SD, and median and interquartile range. * Statistically significant differences.
  2. p-value1: significance between phenotype MS in non-MS patients.
  3. p-value2: significance between phenotype MS in MS patients.
  4. p-value3: significance between MS status.